Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study

The original version of the published Article contained an incorrect citation for reference 20 “Hubbard, B. P. & Sinclair, D. A. Measurement of sirtuin enzyme activity using a substrate-agnostic fluorometric nicotinamide assay. Methods Mol. Biol. 1077, 167–177 (2013).” The citation for reference...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ryan W. Dellinger, Santiago Roel Santos, Mark Morris, Mal Evans, Dan Alminana, Leonard Guarente, Eric Marcotulli
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2018
Materias:	Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/4ad9d9e6d3a4470ca37aec031a9b1b39
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4ad9d9e6d3a4470ca37aec031a9b1b39
record_format	dspace
spelling	oai:doaj.org-article:4ad9d9e6d3a4470ca37aec031a9b1b392021-12-02T16:05:43ZAuthor Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study10.1038/s41514-018-0027-12056-3973https://doaj.org/article/4ad9d9e6d3a4470ca37aec031a9b1b392018-08-01T00:00:00Zhttps://doi.org/10.1038/s41514-018-0027-1https://doaj.org/toc/2056-3973The original version of the published Article contained an incorrect citation for reference 20 “Hubbard, B. P. & Sinclair, D. A. Measurement of sirtuin enzyme activity using a substrate-agnostic fluorometric nicotinamide assay. Methods Mol. Biol. 1077, 167–177 (2013).” The citation for reference 20 has been changed to “Cheng, Y. et al. SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury. Apoptosis 21 (8), 905-916 (2016)”. The original version of the published Article did not list a source for the placebo pills or the investigational product NRPT in the Intervention section of Methods. The last sentence of the Intervention section of Methods now lists the source for the placebo pills and the investigational product NRPT as follows: “The matched placebo pills and the investigational product (NRPT) were provided by Elysium Health (New York, NY)”. This has now been corrected in the PDF and HTML versions of the Article.Ryan W. DellingerSantiago Roel SantosMark MorrisMal EvansDan AlminanaLeonard GuarenteEric MarcotulliNature PortfolioarticleGeriatricsRC952-954.6ENnpj Aging and Mechanisms of Disease, Vol 4, Iss 1, Pp 1-1 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Geriatrics RC952-954.6
spellingShingle	Geriatrics RC952-954.6 Ryan W. Dellinger Santiago Roel Santos Mark Morris Mal Evans Dan Alminana Leonard Guarente Eric Marcotulli Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
description	The original version of the published Article contained an incorrect citation for reference 20 “Hubbard, B. P. & Sinclair, D. A. Measurement of sirtuin enzyme activity using a substrate-agnostic fluorometric nicotinamide assay. Methods Mol. Biol. 1077, 167–177 (2013).” The citation for reference 20 has been changed to “Cheng, Y. et al. SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury. Apoptosis 21 (8), 905-916 (2016)”. The original version of the published Article did not list a source for the placebo pills or the investigational product NRPT in the Intervention section of Methods. The last sentence of the Intervention section of Methods now lists the source for the placebo pills and the investigational product NRPT as follows: “The matched placebo pills and the investigational product (NRPT) were provided by Elysium Health (New York, NY)”. This has now been corrected in the PDF and HTML versions of the Article.
format	article
author	Ryan W. Dellinger Santiago Roel Santos Mark Morris Mal Evans Dan Alminana Leonard Guarente Eric Marcotulli
author_facet	Ryan W. Dellinger Santiago Roel Santos Mark Morris Mal Evans Dan Alminana Leonard Guarente Eric Marcotulli
author_sort	Ryan W. Dellinger
title	Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_short	Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_full	Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_fullStr	Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_full_unstemmed	Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
title_sort	author correction: repeat dose nrpt (nicotinamide riboside and pterostilbene) increases nad+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
publisher	Nature Portfolio
publishDate	2018
url	https://doaj.org/article/4ad9d9e6d3a4470ca37aec031a9b1b39
work_keys_str_mv	AT ryanwdellinger authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT santiagoroelsantos authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT markmorris authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT malevans authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT danalminana authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT leonardguarente authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy AT ericmarcotulli authorcorrectionrepeatdosenrptnicotinamideribosideandpterostilbeneincreasesnadlevelsinhumanssafelyandsustainablyarandomizeddoubleblindplacebocontrolledstudy
_version_	1718385144327307264

Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study

Ejemplares similares